Your browser doesn't support javascript.
loading
Erratum to "Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial" [Radiother. Oncol. 147 (2020) 75-83].
van der Valk, Maxime J M; Marijnen, Corrie A M; van Etten, Boudewijn; Dijkstra, Esmée A; Hilling, Denise E; Meershoek-Klein Kranenbarg, Elma; Putter, Hein; Roodvoets, Annet G H; Bahadoer, Renu R; Fokstuen, Tone; Jan Ten Tije, Albert; Capdevila, Jaume; Hendriks, Mathijs P; Edhemovic, Ibrahim; Cervantes, Andrès M R; de Groot, Derk Jan A; Nilsson, Per J; Glimelius, Bengt; van de Velde, Cornelis J H; Hospers, Geke A P.
Afiliação
  • van der Valk MJM; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: mvandervalk@lumc.nl.
  • Marijnen CAM; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Etten B; Department of Surgery, University of Groningen, University Medical Center Groningen, The Netherlands.
  • Dijkstra EA; Department of Medical Oncology, University of Groningen, The Netherlands.
  • Hilling DE; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Meershoek-Klein Kranenbarg E; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Putter H; Department of Medical Statistics, Leiden University Medical Center, The Netherlands.
  • Roodvoets AGH; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bahadoer RR; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Fokstuen T; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Jan Ten Tije A; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands.
  • Capdevila J; Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.
  • Edhemovic I; Department of Surgical Oncology, Institute of Oncology Ljubljana, Slovenia.
  • Cervantes AMR; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Spain.
  • de Groot DJA; Department of Medical Oncology, University of Groningen, The Netherlands.
  • Nilsson PJ; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • van de Velde CJH; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hospers GAP; Department of Medical Oncology, University of Groningen, The Netherlands. Electronic address: g.a.p.hospers@umcg.nl.
Radiother Oncol ; 147: e1, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32564889
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article